ReviewMayo Clinic proceedings2016
Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program.
Review in Mayo Clinic proceedings, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- When Zero Investment Does Not Mean Zero Financial Interest: Risks of Interpreting Ownership Data in Open Payments.Cureus · 2026Article
- Article
- Scientific Meetings in Medical Oncology: Are We Facing a Time- and Resource-Consuming Plethora?Current oncology (Toronto, Ont.) · 2026Article
- Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan.Journal of the American Heart Association · 2024Article
- Article
- Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States.Gynecologic oncology · 2024Article
- Article
- Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019.Scientific reports · 2023Article
- Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.PloS one · 2023Article
- Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic.Cureus · 2022Article
- The intersection of the sunshine act, sutton's law, and the pandemic.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022Article
- Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.Journal of the National Comprehensive Cancer Network : JNCCN · 2021Article
- Conflicts of Interest Among Authors of Systematic Reviews and Meta-analyses Investigating Interventions for Melanoma: Cross-sectional Literature Study.JMIR dermatology · 2021Article
- Financial Conflicts of Interest of United States-Based Authors in Neurology Journals: Cross-Sectional Study Using the Open Payments Database.Neurology · 2021Article
- Conflicts of Interest in Inflammatory Bowel Disease Articles on UpToDate.Journal of the Canadian Association of Gastroenterology · 2021Article
- How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan.Frontiers in public health · 2021Article
- Analysis of payments to GI physicians in the United States: Open payments data study.JGH open : an open access journal of gastroenterology and hepatology · 2020Article
- Quantification of Conflicts of Interest in an Online Point-of-Care Clinical Support Website.Science and engineering ethics · 2020Article
- Association between physician characteristics and payments from industry in 2015-2017: observational study.BMJ open · 2019Observational
- Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.BMJ open · 2019Observational
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
The Centers for Medicare and Medicaid Services' Open Payments program implements Section 6002 of the Affordable Care Act requiring medical product manufacturers to report payments made to physicians or teaching hospitals as well as ownership or investment interests held by physicians in the manufacturer. To determine the characteristics and distribution of these industry payments by specialty, we analyzed physician payments made between August 1, 2013, and December 31, 2013, that were publicly disclosed by Open Payments. We compared payments between specialty types (medical, surgical, and other) and across specialties within each type using the Pearson χ(2) test and the Kruskal-Wallis test. The number of physicians receiving payments was compared with the total number of active physicians in each specialty in 2012. We also analyzed physician ownership interests. Allopathic and osteopathic physicians received 2.43 million payments totaling $475 million. General payments represented 90% of payments by total value ($430 million) (per-physician median, $100; interquartile range [IQR], $31-$273; mean ± SD, $1407±$23,766), with the remaining 10% ($45 million) as research payments (median, $2365; IQR, $592-$8550; mean ± SD, $12,880±$66,743). Physicians most likely to receive general payments were cardiovascular specialists (78%) and neurosurgeons (77%); those least likely were pathologists (9%). Reports of ownership interest in reporting entities included $310 million in dollar amount invested and $447 million in value of interest held by 2093 physicians. In conclusion, the distribution and characteristics of industry payments to physicians varied widely by specialty during the first half-year of Open Payments reporting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.